Vision: Our vision is to unlock therapeutic avenues for human diseases that currently do not have any cure. Our approach focuses on targeting the crux of genetic information flow into proteins in a manner yielding a favorable proteome to treat diseases. The crux we pursue is the ribosomes or their job of mRNA translation into proteins. Mission: Currently, we are developing biological systems that serve as platforms to screen the drugs targeting the ribosome and mRNA translation in various disease models.